Synapse - Genitourinary Oncology Service

Results (167)

Prostate cancer

Book Section

Chen, Y.; Arora, V. K.; Sawyers, C. L.
In DeVita, V. T. Jr; Lawrence, T. S.; Rosenberg, S. A. (Eds.) Cancer: Principles & Practice of Oncology: Primer of the Molecular Biology of Cancer. 1st ed (2011)

Fulltext@MSK | Save

Evaluation of circulating tumor cell (CTC) enumeration as an efficacy response biomarker of overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC): Planned final analysis (FA) of COU-AA-301, a randomized, double-blind, placebo-controlled, phase III study of abiraterone acetate (AA) plus low-dose prednisone (P) post docetaxel

Meeting Abstract

Scher, H. I.; Heller, G.; Molina, A.; Kheoh, T. S.; Attard, G.; Moreira, J.; Sandhu, S. K.; Parker, C.; Logothetis, C.; McCormack, R. T.; more...
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Clinical features of germ cell tumors (GCT) in men age 50 or older: Successful outcome and tolerability to chemotherapy for advanced disease

Meeting Abstract

Voss, M. H.; Jacobsen, E. P.; Patil, S.; Turkula, S.; Jia, X.; Sheinfeld, J.; Bajorin, D. F.; Bosl, G. J.; Motzer, R. J.; Feldman, D. R.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Molecular classification of sunitinib response in metastatic renal cell carcinoma (mRCC) patients by gene expression profiling

Meeting Abstract

Thodima, V. J.; Molina, A. M.; Jia, X.; Zhang, J.; Georges, M. E.; Patil, S.; Reuter, V. E.; Motzer, R. J.; Chaganti, R. S.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Prevalence of prostate cancer (PC) clinical states (CS) in the United States: Estimates using a dynamic progression model

Meeting Abstract

Solo, K.; Mehra, M.; Dhawan, R.; Valant, J.; Scher, H. I.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Quantifying the effect of everolimus on both tumor growth and new metastases in metastatic renal cell carcinoma (RCC): A dynamic tumor model of the RECORD-1 phase III trial

Meeting Abstract

Stein, A. M.; Carter, A.; Hollaender, N.; Motzer, R. J.; Sarr, C.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

A six-gene panel that predicts survival in men with castration-resistant prostate cancer

Meeting Abstract

Subudhi, S. K.; Heller, G.; Anand, A.; Danila, D. C.; Fleisher, M.; Scher, H. I.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

A phase I dose-escalation trial of vaccine replicon particles (VRP) expressing prostate-specific membrane antigen (PSMA) in patients (pts) with castration-resistant prostate cancer (CRPC): Final results

Meeting Abstract

Slovin, S. F.; Morris, S.; Kargman, M.; Durso, R.; Curley, T.; Israel, R. J.; Olson, W. C.; Murphy, D.; Scher, H. I.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Axitinib versus sorafenib as second-line therapy for metastatic renal cell carcinoma (mRCC): Results of phase III AXIS trial

Meeting Abstract

Rini, B. I.; Escudier, B.; Tomczak, P.; Kaprin, A.; Hutson, T. E.; Szczylik, C.; Tarazi, J. C.; Rosbrook, B.; Kim, S.; Motzer, R. J.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

A phase III, randomized study of the investigational agent TAK-700 plus prednisone for patients with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC)

Meeting Abstract

Saad, F.; Akaza, H.; Eisenberger, M. A.; Nelson, J.; Scher, H. I.; Suzuki, K.; Wirth, M.; Webb, I. J.; Wang, J.; MacLean, D.; more...
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save